Quick answer: Can you get a Wegovy prescription in Australia?
Yes—Wegovy (semaglutide 2.4 mg) is available via prescription in Australia for chronic weight management, subject to clinical assessment. It is a Schedule 4 (prescription‑only) medicine. Supply can vary by pharmacy and state; many pharmacies operate waitlists.
- Prescription route: GP, endocrinologist or obesity medicine prescriber (in‑clinic or telehealth)
- Dispensing: Community or specialty pharmacies; private (not PBS‑subsidised)
- Requirements: Lifestyle measures plus clinical eligibility; ongoing review
Who is eligible for Wegovy?
Doctors typically consider Wegovy for adults with:
- BMI ≥ 30 kg/m²; or
- BMI ≥ 27 kg/m² with at least one weight‑related comorbidity (for example hypertension, dyslipidaemia, obstructive sleep apnoea, prediabetes/type 2 diabetes, cardiovascular risk, PCOS, or NAFLD as part of a broader risk profile)
Eligibility also depends on medical history, current medications, previous weight‑management attempts, and readiness to maintain nutrition, movement and behavioural strategies alongside therapy.
Which doctors can prescribe Wegovy in Australia?
Most Australian GPs can prescribe Wegovy where clinically appropriate. Endocrinologists, bariatric/obesity medicine clinicians and some specialised weight‑management telehealth services also prescribe. Expect a thorough assessment covering:
- Weight history, lifestyle and prior interventions
- Comorbidities, medications and contraindication screening
- Shared decision‑making on benefits, risks and alternatives
- Monitoring plan for dose titration, tolerability and progress
How a Wegovy prescription process usually works
- Initial consult (GP or specialist): medical review, measurements and eligibility check
- Discuss options: Wegovy vs alternatives (Saxenda, Ozempic for T2D, tirzepatide for T2D), lifestyle plan and side‑effect counselling
- Prescription: private script; pharmacy places an order or adds you to a waitlist if stock is constrained
- Dose titration: typically gradual weekly increases toward a maintenance dose if tolerated; your doctor sets the schedule and reviews as needed
- Follow‑up: monitor weight, waist, tolerability and relevant biomarkers; adjust plan accordingly
Pharmacy access, stock and supply notes
- Availability: Pharmacies may have limited supply; many maintain waitlists and prioritise existing patients
- Dispensing: Private prescription; pharmacies may need to order specific strengths
- Cold chain: Pens require temperature‑controlled handling—use reputable pharmacies only
- Importing: Import rules are strict and counterfeit risk is high—most people should use local prescriber + pharmacy pathways
Costs and budgeting
Wegovy is generally not PBS‑subsidised for weight management. Private pricing varies by pharmacy, state and dose. Expect separate fees for consultations and follow‑ups. To plan out‑of‑pocket costs and typical ranges:
Alternatives to discuss with your doctor
- Ozempic vs Wegovy (same molecule, different approved indications and doses)
- Wegovy vs Saxenda (weekly semaglutide vs daily liraglutide)
- Mounjaro vs Wegovy (tirzepatide vs semaglutide comparisons)
- For broader GLP‑1 background: GLP‑1 Australia Guide
If you have type 2 diabetes, your doctor may prioritise diabetes‑indicated products (for example Ozempic or Trulicity) depending on your clinical picture.
Safety overview and side effects
Commonly reported effects include nausea, vomiting, diarrhoea/constipation and reduced appetite—often during dose escalation. Doctors screen for red flags and interactions, and provide strategies to improve tolerability (for example slower titration, nutrition adjustments).
Always seek medical advice promptly if you experience severe or persistent symptoms. For a detailed overview of risks, warnings and when to seek help: Wegovy Side Effects
This page is educational and does not replace individual medical advice. Peptide Help does not sell or advertise prescription medicines. Talk to your healthcare professional for guidance specific to you.
Evidence snapshot (what studies suggest)
Large randomised trials of semaglutide for chronic weight management have shown clinically meaningful average weight reduction when combined with lifestyle measures. Results vary widely by person, adherence, dose and duration. Your prescriber will set expectations and monitoring tailored to your goals.
For brand‑specific use, dosing and warnings, follow the Australian Product Information and your clinician’s instructions.
Frequently asked questions
Is Wegovy different to Ozempic?
They contain the same active ingredient (semaglutide) but are approved for different indications and dosing schedules. See Ozempic vs Wegovy for a clear comparison.
Do I need in‑person visits or can this be telehealth?
Many clinics offer telehealth for screening and follow‑up. You may still need in‑person checks for vitals and labs depending on your situation.
How long do people usually stay on therapy?
Duration is individual and guided by outcomes, tolerability and safety. Doctors review continuation at regular intervals.
What if my pharmacy is out of stock?
Ask to join a waitlist and check neighbouring pharmacies. Your prescriber may discuss interim strategies or alternatives if appropriate.
Where can I learn about total costs?
Consultation, medication and review costs vary. See Wegovy Cost Australia for guidance, then confirm with your clinic and pharmacy.
What should I prepare for my consult?
List your medications, medical history, previous weight‑management attempts, and bring recent measurements (weight, waist, blood pressure if available). Be ready to discuss nutrition, movement and sleep habits.
Free, no‑obligation eligibility check
Answer a few questions and we’ll connect you with an Australian prescriber or clinic that can review your eligibility and discuss options, costs and pharmacy access.
We aim to respond within 1–2 business days.
Key takeaways
- Wegovy requires a prescription in Australia—GPs and specialists can assess eligibility
- Stock is variable; reputable pharmacies and waitlists are common
- Costs are private—budget for consults, medication and follow‑ups
- Discuss alternatives if you’re not eligible or if supply is constrained